These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33414414)
1. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4 Xu R; Wu M; Liu S; Shang W; Li R; Xu J; Huang L; Wang F Cell Death Dis; 2021 Jan; 12(1):22. PubMed ID: 33414414 [TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism and function of CD4 Wu M; Fu X; Xu R; Liu S; Li R; Xu J; Shang W; Chen X; Wang T; Wang F Cancer Med; 2023 Aug; 12(15):16310-16322. PubMed ID: 37317670 [TBL] [Abstract][Full Text] [Related]
3. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy. Li L; Liu X; Sanders KL; Edwards JL; Ye J; Si F; Gao A; Huang L; Hsueh EC; Ford DA; Hoft DF; Peng G Cell Metab; 2019 Jan; 29(1):103-123.e5. PubMed ID: 30344014 [TBL] [Abstract][Full Text] [Related]
4. Ovarian Cancer Cells Promote Glycolysis Metabolism and TLR8-Mediated Metabolic Control of Human CD4 Shang W; Xu R; Xu T; Wu M; Xu J; Wang F Front Oncol; 2020; 10():570899. PubMed ID: 33102225 [TBL] [Abstract][Full Text] [Related]
5. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. Efimova O; Szankasi P; Kelley TW PLoS One; 2011 Jan; 6(1):e16013. PubMed ID: 21253614 [TBL] [Abstract][Full Text] [Related]
6. TLR8 reprograms human Treg metabolism and function. Liu X; Li L; Peng G Aging (Albany NY); 2019 Sep; 11(17):6614-6615. PubMed ID: 31487689 [No Abstract] [Full Text] [Related]
8. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro]. Wang ZH; Zhu JY; Li T; Leng XS Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991 [TBL] [Abstract][Full Text] [Related]
9. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169 [TBL] [Abstract][Full Text] [Related]
10. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562 [TBL] [Abstract][Full Text] [Related]
11. TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy. Amiset L; Fend L; Gatard-Scheikl T; Rittner K; Duong V; Rooke R; Muller S; Bonnefoy JY; Préville X; Haegel H Oncoimmunology; 2012 Nov; 1(8):1271-1280. PubMed ID: 23243590 [TBL] [Abstract][Full Text] [Related]
12. CD4 Liu S; Tao Z; Lou J; Li R; Fu X; Xu J; Wang T; Zhang L; Shang W; Mao Y; Wang F J Transl Med; 2023 Nov; 21(1):803. PubMed ID: 37950246 [TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer. Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430 [TBL] [Abstract][Full Text] [Related]
15. TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment. Wu M; Chen X; Lou J; Zhang S; Zhang X; Huang L; Sun R; Huang P; Wang F; Pan S Oncotarget; 2016 Jul; 7(28):44534-44544. PubMed ID: 27322208 [TBL] [Abstract][Full Text] [Related]
16. Functional control of regulatory T cells and cancer immunotherapy. Wang RF Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537 [TBL] [Abstract][Full Text] [Related]
17. CD49d Treg cells with high suppressive capacity are remarkably less efficient on activated CD45RA- than on naive CD45RA+ Teff cells. Kraczyk B; Remus R; Hardt C Cell Physiol Biochem; 2014; 34(2):346-55. PubMed ID: 25060807 [TBL] [Abstract][Full Text] [Related]
18. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
19. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer. Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967 [TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA confers neuroprotection after optic nerve injury by suppressing CD4+CD25+ regulatory T-cell activity. Johnson TV; Camras CB; Kipnis J Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3441-9. PubMed ID: 17652711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]